Merck and Moderna's cancer vaccine works. Making it affordable is the next test
- Moderna: 2 events in the last 90 days
- Previous: 32 days earlier · Quant funds rocked as Treasury boosts buybacks and Moderna shares leap
What happened
Merck and Moderna build a custom mRNA vaccine for each melanoma patient from tumor mutations. The strategy stumbles in cancers lacking enough targets
Summary assembled by rule from the sources below